Elsevier

Gynecologic Oncology

Volume 70, Issue 2, August 1998, Pages 241-246
Gynecologic Oncology

Regular Article
Radiation Therapy of Pelvic Recurrence after Radical Hysterectomy for Cervical Carcinoma

https://doi.org/10.1006/gyno.1998.5093Get rights and content

Abstract

Objectives.To evaluate the efficacy of radiation therapy and potential prognostic factors in patients treated for pelvic recurrence of cervical carcinoma after radical hysterectomy.

Materials.The records of 50 patients treated between 1964 and 1994 for an isolated pelvic recurrence of cervical carcinoma a median of 10.5 months after initial radical hysterectomy were retrospectively reviewed. Patients were categorized according to the extent of disease on clinical examination as group 1, mucosal involvement only (5); group 2, paravaginal extension (11); group 3, central recurrence with pelvic wall extension (13); and group 4, recurrences limited to the pelvic sidewall (21). Seven patients with group 3 or 4 disease who had a poor performance status were treated with palliative intent using hypofractionated radiotherapy. The remaining 43 patients were treated with curative intent, 33 with radiotherapy only and 10 with a combination of cisplatin-based chemotherapy and radiotherapy. Survival rates were calculated from the date of initial recurrence. Median follow-up of surviving patients was 109 months.

Results.The overall 5-year survival rate was 33% for all 50 patients (median survival, 18 months), 39% for the 43 patients treated with curative intent, and 25% for patients with isolated sidewall recurrences treated with curative intent. The survival rate was 69% for patients with group 1 and 2 disease and 18% for those treated with curative intent for group 3 disease (P= 0.07). The survival rate was better for patients with recurrent squamous carcinomas (51%) than for those with adenocarcinomas (14%) (P= 0.05). Three group 4 patients who survived more than 5 years were treated with external-beam radiation alone. Eight-one percent of patients who had a second recurrence had evidence of disease progression. Three patients experienced late treatment complications.

Conclusions.Patients who experience an isolated recurrence of cervical cancer after initial radical hysterectomy have an excellent prognosis if disease does not involve the pelvic wall. Occasional long-term survivors of recurrent disease involving the pelvic wall justify an aggressive treatment approach.

Cited by (81)

  • Invasive cervical cancer

    2023, DiSaia and Creasman Clinical Gynecologic Oncology
  • Computed Tomography-Based Interstitial Brachytherapy for Recurrent Cervical Carcinoma in the Vaginal Apex

    2022, Clinical Oncology
    Citation Excerpt :

    Disease-free survival (DFS) after radiotherapy is 40–50% in patients with localised central pelvic recurrence. However, when the recurrences are nodal or in the pelvic sidewalls, DFS is only 12–15% after radiotherapy [6–9]. This suggests that the radiation dose delivered presently may not be sufficient to obtain adequate local control in all cases, particularly in the presence of pelvic sidewall disease, and also that the recurrent tumours may have an aggressive feature that limits their radiocurability.

  • Molecular landscape of recurrent cervical cancer

    2021, Critical Reviews in Oncology/Hematology
  • Cancers of the Cervix, Vulva, and Vagina

    2019, Abeloff’s Clinical Oncology
  • Invasive cervical cancer

    2018, Clinical Gynecologic Oncology
  • Cervical Cancer

    2015, Clinical Radiation Oncology
View all citing articles on Scopus
1

To whom reprint requests should be addressed. Fax (713) 792-3642.

View full text